| Product ID | 42571-381_e4508328-6e1f-4234-e053-2995a90a4a40 |
| NDC | 42571-381 |
| Product Type | Human Prescription Drug |
| Proprietary Name | CHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE |
| Generic Name | Chlordiazepoxide Hcl And Clidinium Bromide |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-10-01 |
| Marketing Category | ANDA / |
| Application Number | ANDA215835 |
| Labeler Name | Micro Labs Limited |
| Substance Name | CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE |
| Active Ingredient Strength | 5 mg/1; mg/1 |
| Pharm Classes | Anticholinergic [EPC], Benzodiazepine [EPC], Benzodiazepines [CS], Cholinergic Antagonists [MoA], Decreased Parasympathetic Acetylcholine Activity [PE], Digestive/GI System Activity Alteration [PE], GI Motility Alteration [PE] |
| DEA Schedule | CIV |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |